EnsoData has assisted clinicians in diagnosing the one millionth patient supported by its AI/ML sleep scoring solution, EnsoSleep, the company announced today.

“Now that we have helped clinicians read one million studies and reach one million patients, we’re only doubling down on our mission to positively impact patient care and make healthcare more accessible and affordable–to reach the next 10 million patients that need help,” EnsoData Executive Chairman and Co-Founder Chris Fernandez said in a statement.

According to a release, EnsoData is helping clinician staffing shortages by automating the time-consuming process of scoring Polysomnography (PSG) and Home Sleep Apnea Tea (HSAT) sleep studies.

To date, the company has done more than 450,000 Polysomnography (PSG) studies, and health systems like Rush University, Advanced Sleep Management and CHI St. Joseph Health support its technology.